Patient radiation doses in paediatric interventional cardiology procedures: a review

R W Harbron1,2, S Dreuil3, M-O Bernier3

  • 1Institute of Health and Society, Newcastle University, Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne, NE1 4LP, UK.

Insights

Pediatric interventional cardiology X-ray procedures show wide radiation dose variations, with no clear reduction over 15 years. Further research is needed to link radiation exposure to patient outcomes.

Area of Science:

  • Medical Imaging
  • Pediatric Cardiology
  • Radiation Dosimetry

Background:

  • Numerous studies have investigated radiation doses in pediatric interventional cardiology.
  • Data collection focused on kerma area product (PKA) and fluoroscopic screening time (FT), often omitting patient dose estimation.
  • Significant variability exists in reported PKA values across studies, even when stratified by patient demographics.

Purpose of the Study:

  • To review and synthesize recent investigations on radiation doses in pediatric X-ray guided interventional cardiology.
  • To analyze trends and variations in dose metrics like PKA, fluoroscopic time, and effective/organ doses.
  • To assess the impact of radiation dose in relation to patient outcomes.

Main Methods:

  • Systematic review of recent studies on pediatric interventional cardiology radiation doses.
  • Data extraction for kerma area product (PKA), fluoroscopic screening time (FT), air kerma, effective dose, and organ doses.
  • Analysis of dose variations based on patient age, weight, and specific procedures.

Main Results:

  • A wide range of PKA values were observed, with significant variations (greater than ten-fold) between studies.
  • Typical PKA values varied considerably by age group and procedure type, with pulmonary artery angioplasty and right ventricular outflow tract dilatation showing higher doses.
  • Effective dose estimates (3-15 mSv) were common but limited for individual risk assessment; organ dose estimations were rare.
  • No clear reduction in dose indicators (PKA, air kerma) was observed over the last 15 years, irrespective of detector technology (flat panel vs. image intensifiers).

Conclusions:

  • Radiation doses in pediatric interventional cardiology remain highly variable and have not shown a significant decrease over time.
  • Current dose metrics like effective dose have limitations for personalized risk assessment.
  • There is a need to assess the clinical impact of these radiation doses in the context of patient outcomes.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
660
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
570
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
564
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
486
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411